Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCV

Journal of Hepatology

Volumn 45, Issue 6, 2006, Pages 770-778

  Deterding, Katja ^a   Tegtmeyer, Björn ^a   Cornberg, Markus ^a   Hadem, Johannes ^a   Potthoff, Andrej ^a   Böker, Klaus H W ^a   Tillmann, Hans L ^a   Manns, Michael P ^a   Wedemeyer, Heiner ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Co infections; Fulminant hepatic failure; Hepatitis A virus infection; Hepatitis C virus infection; Viral interaction

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; VIRUS RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; FOLLOW UP; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS C; HUMAN; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS REPLICATION;

ACUTE DISEASE; ADULT; AGED; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS A VIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RNA, VIRAL; SUPERINFECTION; TIME FACTORS; VIRAL INTERFERENCE; VIRUS REPLICATION;

EID: 33750445939     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2006.07.023     Document Type: Article

References (40)

1. Feinstone S.M., Kapikian A.Z., and Purceli R.H. Hepatitis A: detection by immune electron microscopy of a virus like antigen associated with acute illness. Science 182 (1973) 1026-1028
2. Hadem J. Immunopathogenesis and treatment of hepatitis A. In: Gershwin M.E., Vierling J.M., and Manns M.P. (Eds). Liver immunology (2003), Hanley&Belfus, Inc., Philadelphia 185-201
3. Keeffe E.B. Acute hepatitis A and B in patients with chronic liver disease: prevention through vaccination. Am J Med 118 (2005) 21S-27S
4. Ostapowicz G., Fontana R.J., Schiodt F.V., Larson A., Davern T.J., Han S.H., et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 137 (2002) 947-954
5. Bell B.P., Shapiro C.N., Alter M.J., Moyer L.A., Judson F.N., Mottram K., et al. The diverse patterns of hepatitis A epidemiology in the United States-implications for vaccination strategies. J Infect Dis 178 (1998) 1579-1584
6. Sagnelli E., Coppola N., Scolastico C., Filippini P., Santantonio T., Stroffolini T., et al. Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis. Hepatology 32 (2000) 1106-1110
7. Liaw Y.F. Concurrent hepatitis B and C virus infection: Is hepatitis C virus stronger?. J Gastroenterol Hepatol 16 (2001) 597-598
8. Mathurin P., Thibault V., Kadidja K., Ganne-Carrie N., Moussalli J., El Younsi M., et al. Replication status and histological features of patients with triple (B, C, D) and dual (B, C) hepatic infections. J Viral Hepat 7 (2000) 15-22
9. Jardi R., Rodriguez F., Buti M., Costa X., Cotrina M., Galimany R., et al. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference. Hepatology 34 (2001) 404-410
10. Almasio P.L., and Amoroso P. HAV infection in chronic liver disease: a rationale for vaccination. Vaccine 21 (2003) 2238-2241
11. Vento S., Garofano T., Renzini C., Cainelli F., Casali F., Ghironzi G., et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med 338 (1998) 286-290
12. Helbling B., Renner E.L., and Kammerlander R. Acute hepatitis A in patients with chronic hepatitis C. Ann Intern Med 131 (1999) 314
13. Devalle S., de Paula V.S., de Oliveira J.M., Niel C., and Gaspar A.M. Hepatitis A virus infection in hepatitis C Brazilian patients. J Infect 47 (2003) 125-128
14. Hasle G., Hoel T., and Jensenius M. Mortality of hepatitis A in adults with hepatitis C antibodies. Lancet 351 (1998) 1888
15. Sagnelli E., Coppola N., Pisaturo M., Pisapia R., Onofrio M., Sagnelli C., et al. Clinical and virological improvement of hepatitis B virus-related or hepatitis C virus-related chronic hepatitis with concomitant hepatitis A virus infection. Clin Infect Dis 42 (2006) 1536-1543
16. Bianco E., Stroffolini T., Spada E., Szklo A., Marzolini F., Ragni P., et al. Case fatality rate of acute viral hepatitis in Italy: 1995-2000. An update. Dig Liver Dis 35 (2003) 404-408
17. Rezende G., Roque-Afonso A.M., Samuel D., Gigou M., Nicand E., Ferre V., et al. Viral and clinical factors associated with the fulminant course of hepatitis A infection. Hepatology 38 (2003) 613-618
18. Ishak K., Baptista A., Bianchi L., Callea F., De Groote J., Gudat F., et al. Histological grading and staging of chronic hepatitis. J Hepatol 22 (1995) 696-699
19. Normann A., Jung C., Vallbracht A., and Flehmig B. Time course of hepatitis A viremia and viral load in the blood of human hepatitis A patients. J Med Virol 72 (2004) 10-16
20. Williams R. Classification, etiology, and considerations of outcome in acute liver failure. Semin Liver Dis 16 (1996) 343-348
21. Bradley D.W., Maynard J.E., McCaustland K.A., Murphy B.L., Cook E.H., and Ebert J.W. Non-A, non-B hepatitis in chimpanzees: interference with acute hepatitis A virus and chronic hepatitis B virus infections. J Med Virol 11 (1983) 207-213
22. Bain C., Fatmi A., Zoulim F., Zarski J.P., Trepo C., and Inchauspe G. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology 120 (2001) 512-524
23. Kanto T., Hayashi N., Takehara T., Tatsumi T., Kuzushita N., Ito A., et al. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J Immunol 162 (1999) 5584-5591
24. Sarobe P., Lasarte J.J., Zabaleta A., Arribillaga L., Arina A., Melero I., et al. Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses. J Virol 77 (2003) 10862-10871
25. Crotta S., Stilla A., Wack A., D'Andrea A., Nuti S., D'Oro U., et al. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J Exp Med 195 (2002) 35-41
26. Tseng C.T., and Klimpel G.R. Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J Exp Med 195 (2002) 43-49
27. Keeffe E.B., Iwarson S., McMahon B.J., Lindsay K.L., Koff R.S., Manns M., et al. Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease. Hepatology 27 (1998) 881-886
28. Wedemeyer H., Caselmann W.H., and Manns M.P. Combination therapy of chronic hepatitis C: an important step but not the final goal!. J Hepatol 29 (1998) 1010-1014
29. Wietzke P., Schott P., Braun F., Mihm S., and Ramadori G. Clearance of HCV RNA in a chronic hepatitis C virus-infected patient during acute hepatitis B virus superinfection. Liver 19 (1999) 348-353
30. Gruener N.H., Jung M.C., Ulsenheimer A., Gerlach T.J., Diepolder H.M., Schirren C.A., et al. Hepatitis C virus eradication associated with hepatitis B virus superinfection and development of a hepatitis B virus specific T cell response. J Hepatol 37 (2002) 866-869
31. Schuttler C.G., Fiedler N., Schmidt K., Repp R., Gerlich W.H., and Schaefer S. Suppression of hepatitis B virus enhancer 1 and 2 by hepatitis C virus core protein. J Hepatol 37 (2002) 855-862
32. Shih C.M., Lo S.J., Miyamura T., Chen S.Y., and Lee Y.H. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J Virol 67 (1993) 5823-5832
33. Wedemeyer H., Mizukoshi E., Davis A.R., Bennink J.R., and Rehermann B. Cross-reactivity between hepatitis C virus and Influenza A virus determinant-specific cytotoxic T cells. J Virol 75 (2001) 11392-11400
34. Welsh R.M., and Selin L.K. No one is naive: the significance of heterologous T-cell immunity. Nat Rev Immunol 2 (2002) 417-426
35. Chang M., Williams O., Mittler J., Quintanilla A., Carithers Jr. R.L., Perkins J., et al. Dynamics of hepatitis C virus replication in human liver. Am J Pathol 163 (2003) 433-444
36. Guidotti L.G., and Chisari F.V. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 19 (2001) 65-91
37. Thimme R., Oldach D., Chang K.M., Steiger C., Ray S.C., and Chisari F.V. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 194 (2001) 1395-1406
38. Guo J.T., Bichko V.V., and Seeger C. Effect of alpha interferon on the hepatitis C virus replicon. J Virol 75 (2001) 8516-8523
39. Frese M., Pietschmann T., Moradpour D., Haller O., and Bartenschlager R. Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway. J Gen Virol 82 (2001) 723-733
40. Spada E., Genovese D., Tosti M.E., Mariano A., Cuccuini M., Proietti L., et al. An outbreak of hepatitis A virus infection with a high case-fatality rate among injecting drug users. J Hepatol 43 (2005) 958-964